Community Healthcare Trust Inc (CHCT)
Community Healthcare Trust Inc (CHCT)
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Credit loss reserve | NaN | 0 | 0 | 8,672 |
| Net income | 2,548 | 14,428 | 1,640 | -10,966 |
| Gains on sale, net of impairments of real estate assets | NaN | NaN | NaN | 640 |
| Depreciation and amortization | 10,657 | 10,814 | 10,902 | 21,822 |
| Accelerated amortization of stock-based compensation | NaN | 0 | 0 | 4,591 |
| Other amortization | 392 | 425 | 361 | 544 |
| Stock-based compensation | 2,711 | 2,599 | 2,465 | 5,241 |
| Net gain from insurance recovery on casualty loss | NaN | 0 | NaN | NaN |
| Straight-line rent receivable | 760 | 985 | 913 | 1,823 |
| Deferred income tax expense | NaN | 23 | NaN | NaN |
| Loss on sale of real estate assets | -46 | 12,051 | -248 | NaN |
| Other assets | 591 | 221 | 453 | -1,668 |
| Accounts payable and accrued liabilities | -291 | -991 | -786 | 558 |
| Other liabilities | -972 | 1,459 | -1,382 | -1,459 |
| Funding of notes receivable | NaN | 0 | 0 | 0 |
| Net cash provided by operating activities | 13,740 | 15,500 | 12,722 | 28,208 |
| Acquisitions of real estate | 28,514 | 28,525 | 26,363 | 9,711 |
| Financing transaction investment | 0 | NaN | NaN | NaN |
| Proceeds from sale of real estate | 5,864 | 30,936 | 651 | 615 |
| Proceeds from the repayment of notes receivable | 150 | 130 | 120 | 4,975 |
| Insurance proceeds from casualty loss | NaN | 0 | NaN | NaN |
| Capital expenditures on existing real estate properties | 4,967 | 6,537 | 5,076 | 8,911 |
| Net cash used in investing activities | -27,467 | -3,996 | -30,668 | -13,032 |
| Term loan repayments | NaN | 0 | NaN | NaN |
| Mortgage note repayments | NaN | 0 | 0 | 0 |
| Net borrowings on revolving credit facility | 27,000 | 2,000 | 30,000 | 14,000 |
| Dividends paid | 13,666 | 13,547 | 13,477 | 26,645 |
| Proceeds from issuance of common stock | NaN | 0 | 0 | 0 |
| Taxes paid on behalf of employees and shares withheld upon shares vesting | 298 | 0 | 57 | 1,735 |
| Equity issuance costs | 32 | 0 | 0 | 317 |
| Debt issuance costs | NaN | 0 | NaN | NaN |
| Net cash provided by (used in) financing activities | 13,004 | -11,547 | 16,466 | -14,697 |
| Decrease in cash, cash equivalents and restricted cash | -723 | -43 | -1,480 | 479 |
| Cash, cash equivalents and restricted cash, beginning of period | 3,340 | 3,383 | 4,384 | NaN |
| Cash, cash equivalents and restricted cash, end of period | 2,617 | 3,340 | 3,383 | NaN |